ACOR News and Press, Acorda Therapeutics Inc. From 04/11/21

Investors often shrug off the impact of stimulus, but when fabricated demand comes into the stock market everything is affected, even Acorda Therapeutics (NASDAQ: ACOR) and other stocks that might not be direct beneficiaries.  They say, a rising tide lifts all boats, and multiple e...

Technical analysis provides insights that fundamental observations cannot.  We can use that to our advantage in Acorda Therapeutics (NASDAQ: ACOR).   Using the data offered below we have a real-time example.  Review The technical data for ACOR below, and the added va...

The next move in a stock's price is often identifiable in advance.  This Acorda Therapeutics (NASDAQ: ACOR) report attempts to do that, and in the process help investors learn how price acton can be revealing.  Trading plans for ACOR make these observations actionable, but the...

Our job as investors is to pay attention to the stocks we own.  Part of that involves looking at the fundamentals, but half of the disclosure comes from looking at price action. The Acorda Therapeutics (NASDAQ: ACOR) data table below can help you with price action, and we have more...

Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present during the March 9 th & 10 th H.C. Wainwright Global Life Sciences Virtual Conference. For more information about the conference, please visit the eve...

The following slide deck was published by Acorda Therapeutics, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Acorda Therapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation

Gainers: Second Sight Medical Products (EYES) +337%.AMTD International (HKIB) +27%.Sify Technologies Limited (SIFY) +26%.Boqii Holding Limited (BQ) +25%.ChromaDex Corporation (CDXC) +22%.W&T Offshore (WTI) +21%.Anchiano Therapeutics (ANCN) +18%.Purple Innovation (PRPL) +19%.Plus Ther...

Gainers: Second Sight Medical Products EYES +151%, XTL Biopharmaceuticals (XTLB) +42%, Nurix Therapeutics (NRIX) +9%, Auris Medical Holding (EARS) +5%, Anchiano Therapeutics (ANCN) +5%.Losers: Evofem Biosciences EVFM -34%, T2 Biosystems (...

Acorda Therapeutics, Inc. (ACOR) Q4 2020 Earnings Conference Call March 4, 2021 4:30 P.M. ET Company Participants Tierney Saccavino - Executive Vice President and Corporate Communications Ron Cohen - Chief Executive Officer Conference Call Participants Presentation Operator Welcome to Acorda ...

Acorda Therapeutics (ACOR) shares were choppy during after market trading as the company posted fourth-quarter revenue that beat Wall Street estimates and talked up its financial position, buoyed by the recent sale of its manufacturing operations in Chelsea and its restructuring measures.The ...